Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion - Swissmedic Key 65994003 PP Registration Holder Servier (Suisse) SA Name Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion Date of registration 25.07.2017 Introduction of Sequence 25.07.2017 ATC-Classification Irinotecan (L01CE02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680659940037 Medication Code Synthetika Pharmacode Disponibility
Composition irinotecanum 43 mg ut irinotecani sucrosofas corresp. irinotecani hydrochloridum trihydricum 50 mg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, acidum hydroxyethylpiperazinethansulfonicum, natrii chloridum corresp. natrium 33.1 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml. Packungsbestandteile Galenic Form dispersion à diluer pour perfusion Excipiens Active Agent Dose Irinotecan 43mg / 10ml
Inactive agents 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum Acidum Hydroxyethylpiperazinethansulfonicum Cholesterol N-(carbonyl-Methoxypolyethylenglycoli 2000)-1,2-distearoyl-Sn-Glycero-3-Phosphoethanolaminum Natricum Sodium Chloride
Source Data was imported : 04.05.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
